Literature DB >> 3675904

Rationalized nomenclature for head and neck carcinomas.

W J Richtsmeier, T E Carey.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3675904     DOI： 10.1001/archotol.1987.01860120085018

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


× No keyword cloud information.
  2 in total

1.  Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.

Authors:  Jonah Cohen; Zhong Chen; Shi-Long Lu; Xin Ping Yang; Pattatheyil Arun; Reza Ehsanian; Matthew S Brown; Hai Lu; Bin Yan; Oumou Diallo; Xiao-Jing Wang; Carter Van Waes
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

2.  Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy.

Authors:  Waleed M Abuzeid; Xiaoling Jiang; Guoli Shi; Hui Wang; David Paulson; Koji Araki; David Jungreis; James Carney; Bert W O'Malley; Daqing Li
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.